Hemorrhial Plus
Medical device for the topical treatment of haemorrhoids and anal fissures
Medical device
Topic
Clinic + pharmacy
Proctology
Hemorrhial Plus is a medical device for the topical treatment of haemorrhoids and anal fissures. A formulation designed to reduce acute symptoms and support tissue healing, with a safety profile suitable for continuous use.
Direct topical action and available clinical documentation make it suitable for conservative protocols prior to any surgical approaches.
-
Direct topical action on acute symptoms.
-
Support for tissue healing; suitable profile for continuous use.
-
Placement in pre-surgical conservative protocols.
Specification
Value
Packaging
30 g
Active
Sodium hyaluronate 0,60%
Dihydroquercetin 0.10%
Other ingredients
Chlorhexidine digluconate 0.20%
peppermint oil 0.05%
Packaging
Lithographed aluminium tube + carton + leaflet
Class MD
Class IIA
Instructions
Coajuvant in the treatment of symptoms associated with ano-rectal disorders such as haemorrhoids, proctitis, anal and perianal fissures
Specification
Value
Packaging
30 g
Active
Sodium hyaluronate 0,60%
Dihydroquercetin 0.10%
Other ingredients
Chlorhexidine digluconate 0.20%
peppermint oil 0.05%
Packaging
Lithographed aluminium tube + carton + leaflet
Class MD
Class IIA
Instructions
Coajuvant in the treatment of symptoms associated with ano-rectal disorders such as haemorrhoids, proctitis, anal and perianal fissures
Product with a defined therapeutic indication and clear positioning for both the prescribing professional and the pharmacist. It sits at the intersection of prescription and professional advice, offering the distributor flexibility in network building and portfolio management by account type.
Reference channel
Dual: clinical channel (proctologist, proctological surgeon, GP) and pharmacy channel (advice from the pharmacist trained on the line).
Support included
-
Technical and clinical documentation for Hemorrhial Plus.
- Materials for the ethical channel and specific materials for the pharmacy channel.
- Support with positioning towards distributors with a dual clinical and retail focus.
- Willingness to evaluate agreements covering both distribution channels.
